HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,244,595 | +8.0% | 10,758 | -4.0% | 0.00% | 0.0% |
| Q2 2023 | $1,152,126 | -84.3% | 11,202 | -83.3% | 0.00% | -75.0% |
| Q1 2023 | $7,331,261 | -74.4% | 67,173 | -73.3% | 0.00% | -73.3% |
| Q4 2022 | $28,605,367 | +91.5% | 251,365 | +4.1% | 0.02% | +66.7% |
| Q3 2022 | $14,939,000 | -35.3% | 241,380 | -16.6% | 0.01% | -30.8% |
| Q2 2022 | $23,089,000 | -19.3% | 289,477 | +6.5% | 0.01% | -7.1% |
| Q1 2022 | $28,603,000 | -1.9% | 271,865 | +0.5% | 0.01% | 0.0% |
| Q4 2021 | $29,164,000 | +8.2% | 270,636 | +9.9% | 0.01% | -6.7% |
| Q3 2021 | $26,965,000 | +24.7% | 246,164 | +6.6% | 0.02% | +25.0% |
| Q2 2021 | $21,621,000 | +3.0% | 230,895 | +1.3% | 0.01% | -14.3% |
| Q1 2021 | $20,989,000 | +87.4% | 228,040 | +48.9% | 0.01% | +75.0% |
| Q4 2020 | $11,199,000 | +18.5% | 153,099 | +25.8% | 0.01% | 0.0% |
| Q3 2020 | $9,450,000 | +24.2% | 121,654 | -11.1% | 0.01% | +14.3% |
| Q2 2020 | $7,606,000 | +163.0% | 136,847 | +40.2% | 0.01% | +133.3% |
| Q1 2020 | $2,892,000 | -23.7% | 97,622 | -6.8% | 0.00% | -25.0% |
| Q4 2019 | $3,792,000 | +70.7% | 104,762 | +28.4% | 0.00% | +100.0% |
| Q3 2019 | $2,222,000 | +10.4% | 81,610 | -2.4% | 0.00% | -33.3% |
| Q2 2019 | $2,013,000 | – | 83,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |